MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Mirati Therapeutics Company Profile (NASDAQ:MRTX)

Consensus Ratings for Mirati Therapeutics (NASDAQ:MRTX) (?)
Ratings Breakdown: 3 Hold Rating(s), 5 Buy Rating(s)
Consensus Rating:Buy (Score: 2.63)
Consensus Price Target: $22.88 (310.68% upside)

Analysts' Ratings History for Mirati Therapeutics (NASDAQ:MRTX)
Show:
DateFirmActionRatingPrice TargetActions
6/6/2016BarclaysLower Price TargetOverweight$41.00 -> $27.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/6/2016Leerink SwannDowngradeOutperform -> Market Perform$37.00 -> $20.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/6/2016Citigroup Inc.Lower Price TargetBuy$30.00 -> $23.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/6/2016Jefferies GroupDowngradeBuy -> Hold$27.00 -> $17.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/6/2016WedbushLower Price TargetOutperform$29.00 -> $27.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/12/2016Piper JaffrayInitiated CoverageHold$20.00 -> $17.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/6/2016Avondale PartnersUpgradeMarket Perform -> Market Outperform$22.00 -> $20.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/1/2016SunTrustInitiated CoverageBuy$32.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/1/2015Brean CapitalDowngradeBuy -> HoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/11/2014Johnson RiceUpgradeOverweight -> Focus ListView Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 6/28/2014 forward)
Earnings History for Mirati Therapeutics (NASDAQ:MRTX)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
8/4/2016        
5/5/2016Q1($0.99)($1.13)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/9/2016Q4($1.03)($0.96)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/6/2015($0.88)($1.11)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/6/2015($0.71)($0.77)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/11/2015Q414($0.83)($0.77)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/10/2014Q314($0.76)($0.64)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/8/2014Q214($0.69)($0.82)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/18/2014Q413($0.66)($0.97)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/12/2013Q313($0.78)($2.95)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)
Earnings Estimates for Mirati Therapeutics (NASDAQ:MRTX)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20165($1.19)($0.90)($1.01)
Q2 20165($1.21)($1.00)($1.08)
Q3 20165($1.22)($1.02)($1.10)
Q4 20165($1.22)($0.91)($1.03)
Q1 20171($1.08)($1.08)($1.08)
Q2 20171($1.10)($1.10)($1.10)
Q3 20171($1.12)($1.12)($1.12)
Q4 20171($1.16)($1.16)($1.16)
(Data provided by Zacks Investment Research)
Dividend History for Mirati Therapeutics (NASDAQ:MRTX)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for Mirati Therapeutics (NASDAQ:MRTX)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
6/14/2016Charles M BaumCEOBuy20,000$7.05$141,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/9/2016Bros. Advisors Lp BakerMajor ShareholderSell999,358$9.41$9,403,958.78View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/7/2016Ltd. BraslynMajor ShareholderBuy376,902$9.96$3,753,943.92View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/6/2016Ltd. BraslynMajor ShareholderBuy65,782$18.21$1,197,890.22View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/28/2016Ltd. BraslynMajor ShareholderBuy20,848$19.36$403,617.28View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/18/2016Ltd. BraslynMajor ShareholderBuy1,166$19.34$22,550.44View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/15/2016Mark J. GergenCOOSell10,000$25.92$259,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/16/2015Bros. Advisors Lp BakerMajor ShareholderBuy150,000$45.00$6,750,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/26/2015Jamie ChristensenSVPSell4,750$28.07$133,332.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/5/2015Jamie ChristensenSVPSell6,000$25.41$152,460.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/19/2015Jamie ChristensenSVPSell4,750$22.84$108,490.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/3/2015Orbimed Advisors LlcMajor ShareholderBuy100,000$20.00$2,000,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/29/2015Bros. Advisors Lp BakerMajor ShareholderBuy425,000$20.00$8,500,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/1/2014Orbimed Advisors LlcMajor ShareholderSell107,332$21.66$2,324,811.12View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/26/2013Charles M BaumCEOBuy5,000$16.96$84,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/29/2013Orbimed Advisors LlcMajor ShareholderBuy125,000$17.50$2,187,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/24/2013Tang Capital Partners LpMajor ShareholderBuy57,143$17.50$1,000,002.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/20/2013Tang Capital Partners LpMajor ShareholderSell36,898$16.34$602,913.32View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)
Latest Headlines for Mirati Therapeutics (NASDAQ:MRTX)
DateHeadline
06/28/16 10:07 AMCovering the Bases on Mirati Therapeutics, Inc. (NASDAQ:MRTX): Where is the Stock Going? - Press Telegraph
06/28/16 10:07 AMStrong Sell Calls Recommendations For Mirati Therapeutics, Inc. (NASDAQ:MRTX) At 0 - Investor Newswire
06/25/16 09:03 AMVenbio Select Advisor LLC Increased Mirati Therapeutics INC (NASDAQ:MRTX) by $3.07 Million as Shares Declined - Engelwood Daily
06/24/16 05:14 PMStock in Oversold Area: Mirati Therapeutics, Inc. (NASDAQ:MRTX) - Press Telegraph
06/24/16 05:14 PMHow Many Mirati Therapeutics, Inc. (NASDAQ:MRTX)'s Analysts Are Bearish? - Engelwood Daily
06/23/16 05:46 PMFrontline Trades in Focus: American Express (NYSE:AXP), Mirati Therapeutics (NASDAQ:MRTX), Diamondrock ... - Seneca Globe
06/23/16 05:46 PMMirati Therapeutics, Inc. (NasdaqCM:MRTX) Stock Momentum Hits EXTREME Weakness - CML News
06/23/16 05:46 PMMirati Therapeutics Inc. (MRTX) Hits New 52-week Low During June 20 Session - Equities.com
06/23/16 05:46 PMMirati Therapeutics (MRTX) COO to Step Down - StreetInsider.com
06/23/16 05:46 PMMirati Therapeutics Inc. (MRTX) Hits New 52-week Low During June 21 Session - Equities.com
06/22/16 05:09 PMCOO Mark Gergen Leaving Mirati Therapeutics
06/22/16 03:19 PMMirati Therapeutics Announces Change In Executive Leadership - [at noodls] - SAN DIEGO, June 22, 2016 /PRNewswire/ -- Mirati Therapeutics, Inc. (NASDAQ: MRTX) today announced that Mark Gergen will step down as Executive Vice President and Chief Operations Officer to pursue other ...
06/22/16 03:02 PMMIRATI THERAPEUTICS, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exh -
06/22/16 03:02 PM4:02 pm Mirati Therapeutics announces Mark Gergen will step down as COO to pursue other opportunities -
06/18/16 09:35 AMInsider Buys with dollar amount more than $100 thousand: Mirati Therapeutics Inc.
06/18/16 09:35 AMInsider Buys of More Than $–……,………: Mirati Therapeutics
06/17/16 08:03 AMMirati Therapeutics Inc. (MRTX) Hits New 52-week Low During June 14 Session - Equities.com
06/16/16 06:12 PMInsider Buys of More Than $aaa,aaa: Mirati Therapeutics -
06/16/16 03:03 PMMIRATI THERAPEUTICS, INC. Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financ -
06/15/16 09:52 AMTwo Stocks within Traders Limelight: Mirati Therapeutics, Inc. (NASDAQ:MRTX) , Keryx Biopharmaceuticals, Inc ... - Street Updates
06/13/16 04:54 PMInvestigation for Investors in Shares of Mirati Therapeutics, Inc. (NASDAQ:MRTX) Announced
06/13/16 08:12 AMInvestigation for Investors in Shares of Mirati Therapeutics, Inc. (NASDAQ:MRTX) Announced - Digital Journal
06/13/16 08:12 AMFloating Price Update: Mirati Therapeutics, Inc. (NASDAQ:MRTX) , Dynavax Technologies Corporation (NASDAQ:DVAX) - Street Updates
06/11/16 05:26 PMStocks inside Analysts Limelight: Mirati Therapeutics, Inc. (NASDAQ:MRTX) , Incyte Corporation (NASDAQ:INCY) - Street Updates
06/11/16 08:06 AMA Major Shareholder at Mirati Therapeutics (NASDAQ: MRTX) is Selling Shares - Analyst Ratings
06/10/16 08:12 AMMirati Therapeutics Inc. (MRTX) Hits New 52-week Low During June 08 Session - Equities.com
06/09/16 05:35 PMMirati Therapeutics Inc. (MRTX) Hits New 52-week Low During June 07 Session - Equities.com
06/09/16 05:35 PMMirati Therapeutics Inc. (MRTX) Jumps 5.14% on June 09 - Equities.com
06/09/16 08:10 AMMirati Therapeutics Inc. (MRTX) Drops 9.31% on June 07 - Equities.com
06/08/16 05:42 PMAnalyst Recommendations: Mirati Therapeutics, Inc. (NASDAQ:MRTX), Pure Storage, Inc. (NYSE:PSTG) - Beacon Chronicle
06/08/16 05:42 PMMirati Therapeutics Inc. (MRTX) is Trading Lower on Unusual Volume for June 06 - Equities.com
06/08/16 08:11 AMMirati Therapeutics Inc. (MRTX) Hits New 52-week Low During June 06 Session - Equities.com
06/07/16 05:30 PMTwo Stocks within Analysts Review: AbbVie Inc. (NYSE:ABBV) , Mirati Therapeutics, Inc. (NASDAQ:MRTX) - Street Updates
06/07/16 07:55 AMMIRATI THERAPEUTICS INC. (NASDAQ:MRTX) Financial Condition Compared to S&P 500 - CML News
06/06/16 05:10 PMThe 5 Biggest Biotech and Pharma Losers From ASCO
06/06/16 05:10 PMThese 3 Biotech Stocks Are Getting Killed Today
06/06/16 05:10 PMAnalyst Downgrades: AbbVie Inc, Mirati Therapeutics, Inc., and Barracuda Networks Inc
06/06/16 08:58 AMJefferies Group Lowers Mirati Therapeutics, Inc. (MRTX) to Hold - Let Me Know About This
06/06/16 07:32 AMMIRATI THERAPEUTICS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits -
06/05/16 08:08 AMMirati Therapeutics Provides Progress Update On Current Clinical Trials - [at noodls] - SAN DIEGO, June 5, 2016 /PRNewswire/ -- Mirati Therapeutics, Inc. (NASDAQ: MRTX) today provided an update on three current ongoing clinical programs in patients with non-small cell lung cancer (NSCLC) ...
06/04/16 08:03 AMVenbio Select Advisor LLC Increased Mirati Therapeutics INC (NASDAQ:MRTX) by $3.07 Million as Shares Declined - CCH Daily News
06/02/16 05:38 PMBrokerages give average Rating of “Buy” to Mirati Therapeutics, Inc. (NASDAQ:MRTX) - Let Me Know About This - Brokerages give average Rating of “Buy” to Mirati Therapeutics, Inc. (NASDAQ:MRTX)Let Me Know About ThisMirati Therapeutics logo Mirati Therapeutics, Inc. (NASDAQ:MRTX) has earned an average rating of “Buy” from the ten analysts that are presently covering the firm. One investment analyst has rated the stock with a sell rating, one has assigned a hold ...Stock Review and Earnings Check on Mirati Therapeutics, Inc. (NASDAQ:MRTX)HNNall 2 news articles »
06/02/16 05:38 PMMirati Therapeutics Inc. (MRTX) Jumps 5.24% on June 02 - Equities.com - Mirati Therapeutics Inc. (MRTX) Jumps 5.24% on June 02Equities.comMirati Therapeutics Inc. (MRTX) was among the biggest gainers on the Russell 2000 for Thursday June 02 as the stock popped 5.24% to $19.08, representing a gain of $0.95 per share. Some 226,083 shares traded hands on 1,839 trades, compared with an ...and more »
06/02/16 12:01 PMMirati Therapeutics, Inc. :MRTX-US: Earnings Analysis: Q1, 2016 By the Numbers : June 2, 2016 -
06/02/16 08:11 AMStock Review and Earnings Check on Mirati Therapeutics, Inc. (NASDAQ:MRTX) - HNN - Stock Review and Earnings Check on Mirati Therapeutics, Inc. (NASDAQ:MRTX)HNNCompany earnings are a good way to evaluate the company profitability. Currently, sell-side analysts are expecting Mirati Therapeutics, Inc. (NASDAQ:MRTX) to report quarterly EPS of $-1.15. The company's next earnings report is expected to be published ...and more »
06/01/16 07:13 AMMirati Therapeutics To Present At The Jefferies 2016 Healthcare Conference - [at noodls] - SAN DIEGO, June 1, 2016 /PRNewswire/ -- Mirati Therapeutics, Inc. (NASDAQ: MRTX) today announced that Charles M. Baum, M.D., Ph.D., President and CEO of Mirati, will present a corporate overview at the ...
05/31/16 05:31 PMShare Rating Focus on Mirati Therapeutics, Inc. (NASDAQ:MRTX) - HNN - Share Rating Focus on Mirati Therapeutics, Inc. (NASDAQ:MRTX)HNNThis stock research may entail following what professional equity analysts think about the company. Presently, Wall Street analysts have given a consensus stock rating of 1.33 on shares of Mirati Therapeutics, Inc. (NASDAQ:MRTX). Covering analysts will ...and more »
05/31/16 09:20 AMAfter Last Week What Do Analysts Think Of Mirati Therapeutics, Inc. (MRTX) - Share Trading News - After Last Week What Do Analysts Think Of Mirati Therapeutics, Inc. (MRTX)Share Trading News06/16/2014 – Mirati Therapeutics, Inc. had its “market outperform” rating reiterated by analysts at JMP Securities. They now have a USD 28 price target on the stock. The share price of Mirati Therapeutics, Inc. (MRTX) was up +2.41% during the last ...Mirati Therapeutics, Inc. (NASDAQ:MRTX) Quarterly EPS From Continuing Operations Stands At $-1.1307Vanguard TribuneMirati Therapeutics Incorporated (NASDAQ:MRTX) Short Interest Decreased By 6.73%Franklin IndependentMirati Therapeutics, Inc. (NASDAQ:MRTX) Tracking Stock Rating and Target ProjectionsThe PostEquities Focusall 5 news articles »
05/25/16 12:45 AMMirati Therapeutics Inc (MRTX) Jumps 5.38% on May 23 - Equities.com - Mirati Therapeutics Inc (MRTX) Jumps 5.38% on May 23Equities.comMirati Therapeutics Inc (MRTX) was among the biggest gainers on the Russell 2000 for Monday May 23 as the stock popped 5.38% to $16.86, representing a gain of $0.86 per share. Some 175,626 shares traded hands on 1,893 trades, compared with an ...
05/23/16 03:04 PMMIRATI THERAPEUTICS, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders -
About Mirati Therapeutics

Mirati Therapeutics logo

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: MRTX
  • CUSIP:
Key Metrics:
  • Previous Close: $5.55
  • 50 Day Moving Average: $12.51
  • 200 Day Moving Average: $20.72
  • P/E Ratio: N/A
  • P/E Growth: 0.00
  • Market Cap: $115.45M
  • Current Quarter EPS Consensus Estimate: $-4.55 EPS
Additional Links:
Mirati Therapeutics (NASDAQ:MRTX) Chart for Tuesday, June, 28, 2016


            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha